(XMHQ) S&P MidCap Quality - Overview
Etf: Mid-Cap Stocks, Equity ETF, Quality Screen, S&P 400
Dividends
| Dividend Yield | 0.66% |
| Yield on Cost 5y | 0.98% |
| Yield CAGR 5y | -4.67% |
| Payout Consistency | 88.6% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 17.0% |
| Relative Tail Risk | -3.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.28 |
| Alpha | -6.40 |
| Character TTM | |
|---|---|
| Beta | 0.930 |
| Beta Downside | 0.820 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.56% |
| CAGR/Max DD | 0.65 |
Description: XMHQ S&P MidCap Quality January 08, 2026
The Invesco S&P MidCap Quality ETF (XMHQ) seeks to track an index that selects the highest-quality stocks from the S&P MidCap 400® Index, allocating at least 90 % of its assets to those securities. The fund is a U.S.–based mid-cap blend ETF, designed to give investors exposure to midsize companies that exhibit strong profitability, stable earnings, and solid balance-sheet metrics as defined by the index methodology.
Key additional points to consider: • As of the most recent quarter, XMHQ’s weighted average dividend yield hovered around 1.5 %, reflecting the modest payout profiles typical of quality-oriented mid-caps. • The fund’s top sector allocations are typically information technology, industrials, and health care, sectors that tend to benefit from sustained corporate capital spending and demographic trends. • During periods of rising interest rates, quality mid-caps have historically shown lower volatility than the broader mid-cap universe, with a 12-month rolling beta of roughly 0.85 versus the S&P MidCap 400 index.
If you want a more granular view of XMHQ’s risk-adjusted returns and factor exposures, a quick look at ValueRay’s analytics could be a useful next step.
What is the price of XMHQ shares?
Over the past week, the price has changed by +1.80%, over one month by +2.18%, over three months by +6.55% and over the past year by +8.63%.
Is XMHQ a buy, sell or hold?
What are the forecasts/targets for the XMHQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 122.2 | 12.2% |
XMHQ Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 5.26b USD (5.26b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 5.26b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 5.26b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.34% (E(5.26b)/V(5.26b) * Re(9.34%) + (debt-free company))
Discount Rate = 9.34% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)